Advertisement
News
Subscribe to MDT Magazine News

Antiplatelets: 1 person, 1 dose?

April 14, 2011 12:36 pm | by EurekAlert | Comments

(Montreal Heart Institute) An international consortium of scientists, including major contributions from the Montreal Heart Institute, demonstrates that the "one-size fits all" strategy of uniformly doubling the dose of an antiplatelet drug, clopidogrel, for patients with high...

TOPICS:

American Chemical Society honors Jeremy Berg and Norman Neureiter with Public Service Award

April 14, 2011 12:36 pm | by EurekAlert | Comments

(American Chemical Society) Jeremy M. Berg, Ph.D., director of the National Institute of General Medical Sciences at the National Institutes of Health, and Norman P. Neureiter, Ph.D., senior advisor to the Center for Science Diplomacy at the American Association for the Advancement...

TOPICS:

GOP's Big Pharma Protection to Cost NC Taxpayers "Hundreds of Millions"

April 14, 2011 12:35 pm | by Bio-Medicine.Org | Comments

RALEIGH, N.C., April 14, 2011 /PRNewswire-USNewswire/ -- Attorney General Roy Cooper warned the House Special Select Committee on Tort Reform today that a measure giving immunity to pharmaceutical companies could cost North Carolina taxpayers what one legislator described as "hundreds of...

TOPICS:
Advertisement

Freedom Innovations to Commercialize the World's First Actively-Powered, Complete Lower Extremity Prosthesis

April 14, 2011 12:35 pm | by Bio-Medicine.Org | Comments

IRVINE, Calif., April 14, 2011 /- Freedom Innovations, a company that specializes in the development of high technology lower extremity prosthetic devices, today announced a worldwide licensing agreement. The agreement grants the company exclusive rights to commercialize the world's first...

TOPICS:

New NIST SRM helps improve diagnosis of Huntington's disease

April 14, 2011 12:32 pm | by EurekAlert | Comments

(National Institute of Standards and Technology (NIST)) A new Standard Reference Material from NIST will help clinical genetics labs accurately diagnose Huntington's disease, an inherited degenerative brain disorder.

TOPICS:

Lovelace Health Plan chooses Elsevier/MEDai predictive analytic solutions

April 14, 2011 11:38 am | by EurekAlert | Comments

(Elsevier) Elsevier/MEDai, a leading health information company with award-winning solutions for the improvement of care delivery, announced today that Lovelace Health Plan in New Mexico has purchased several products in MEDai's suite of Risk Navigator products to drive quality...

TOPICS:

Drug potency -- what happens in space?

April 14, 2011 11:38 am | by EurekAlert | Comments

(Springer) Some of the Pharmaceuticals intended for the treatment of minor illnesses of astronauts in space may require special packaging and reformulation to remain stable for long periods in the space environment. That's according to Dr. Putcha and her colleagues from NASA,...

TOPICS:

Van Beek Natural Science's Patented Active Compound in DiaGel Offers one Dose Natural Cure for Pet Bacterial Diarrhea

April 14, 2011 11:36 am | by Bio-Medicine.Org | Comments

ORANGE CITY, Iowa, April 14, 2011 /- Ron Van Beek , president and CEO of Van Beek Natural Science , announced that research conducted at Iowa State University confirmed that the patented active compound, Axaphen, in DiaGel eliminates bacteria on contact. Axaphen was tested using...

TOPICS:
Advertisement

Adeona to Host Conference Call

April 14, 2011 11:35 am | by Bio-Medicine.Org | Comments

ANN ARBOR, Mich., April 14, 2011 /- Adeona Pharmaceuticals, Inc. (AMEX: AEN ), a developer of innovative medicines for serious central nervous system diseases, announced today that it will hold a conference call/audio webcast to discuss the results from the clinical study evaluating...

TOPICS:

PENTERO 900: Elevating Excellence in Microsurgery to a New Level

April 14, 2011 11:35 am | by Bio-Medicine.Org | Comments

DUBLIN, Calif., April 14, 2011 /- Carl Zeiss Meditec, Inc., introduced the all-new PENTERO® 900 surgical microscope system at the 79th Annual Meeting of the American Association of Neurological Surgeons (AANS) in Denver, Colo. Based on the breakthrough OPMI® Pentero surgical...

TOPICS:

Tips For Enjoying A Healthy And Balanced Life

April 14, 2011 11:34 am | by Bio-Medicine.Org | Comments

SHENZHEN, China, April 14, 2011 /PRNewswire-Asia/ In today's modern high-tempo society, people always live a rapid pace of life . Fast food gets more and more popular especially in modern societies in which time is money. People also realize the importance of heath; they pay great...

TOPICS:

Filtering out pesticides with E. coli

April 14, 2011 10:40 am | by EurekAlert | Comments

(Inderscience Publishers) Genetically modified bacteria could be used in air filters to extract pesticide vapors from polluted air thanks to work by researchers in China published this month in the International Journal of Environment and Pollution.

TOPICS:

Tourette Syndrome: non-drug therapy to reduce tics

April 14, 2011 9:40 am | by EurekAlert | Comments

(University of Montreal) The use of cognitive-behavioral therapy to treat tics in Tourette syndrome may be as effective as and even superior to medication in certain cases. According to a new study published in a special edition of the International Journal of Cognitive Therapy by...

TOPICS:

Covidien's updated spine sealant approved by FDA

April 14, 2011 9:36 am | by Mass High Tech: The Journal of New England Technology | Comments

The U.S. Food and Drug Administration has approved Covidien plc's DuraSeal Exact, a spine sealant designed as an improved version of the company's already approved DuraSeal.

TOPICS:

Results From Largest Study of Anti-Rejection Therapy for Heart Transplant Patients Will be Released at ISHLT Meeting

April 14, 2011 9:34 am | by Bio-Medicine.Org | Comments

SAN DIEGO, April 14, 2011 /- New results from the largest multicenter clinical trial for heart transplant patients will be released this week at the International Society for Heart & Lung Transplantation (ISHLT) 31st Annual Meeting and Scientific Sessions in San Diego.  Results...

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading